GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.

Guizhou Xinbang Pharmaceutical Co., Ltd.

002390

CNE100000NG5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 16/07/2024 BST			5-day change	1st Jan Change
3.32 ^CNY	0.00%		+2.15%	-25.23%

07-09	Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	CI
07-08	Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 14, 2023, has closed with 45,659,040 shares, representing 2.37% for CNY 196.2 million.	CI

China Great Wall Asset Management Corporation sold a 1.24% stake in Guizhou Xinbang Pharmaceutical Co., Ltd.

January 24, 2014 at 04:00 am

China Great Wall Asset Management Corporation sold a 1.24% stake in Guizhou Xinbang Pharmaceutical Co., Ltd. (SZSE:002390) on January 23, 2014.

China Great Wall Asset Management Corporation completed the sale of a 1.24% stake in Guizhou Xinbang Pharmaceutical Co., Ltd. (SZSE:002390) on January 23, 2014.

Latest news about Guizhou Xinbang Pharmaceutical Co., Ltd.

Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	07-09	CI
Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 14, 2023, has closed with 45,659,040 shares, representing 2.37% for CNY 196.2 million.	07-07	CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	07-03	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-15	CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	04-01	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Board Appointments	02-21	CI
Xinbang Pharma Chairman Buys 14 Million Yuan More Shares	01-04	MT
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	01-03	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23	CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	09/10/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. commences an Equity Buyback Plan for 14,705,882 shares, representing 0.76% for CNY 200 million, under the authorization approved on July 13, 2023.	14/07/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	26/06/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd.(SZSE:002390) dropped from Shenzhen Stock Exchange Component Index	09/06/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd.(SZSE:002390) dropped from Shenzhen Stock Exchange Component A Share Index	09/06/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	14/04/22	CI
Guizhou Kekai Medicine Co., Ltd. announced that it expects to receive CNY 461.450506 million in funding from Guizhou Xinbang Pharmaceutical Co., Ltd.	05/11/21	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	25/08/21	CI

Chart Guizhou Xinbang Pharmaceutical Co., Ltd.

Duration

Period

Chart Guizhou Xinbang Pharmaceutical Co., Ltd.

More charts

Company Profile

GUIZHOU XINBANG PHARMACEUTICAL Co., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of medical products. The Company operates its businesses through three segments. The Pharmaceutical Manufacturing segment is engaged in the manufacture and distribution of Chinese patent medicines, such as Ginkgo Leaves Tablets. The Pharmaceutical Distribution segment includes rapid wholesale business and medicine retail business. The Medical Services segment is engaged in the provision of medical services. It operates its businesses primarily in domestic markets.

Sector

Pharmaceuticals

Calendar

30/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.	-25.23%	871M
DONG-E-E-JIAO CO.,LTD.	+7.30%	4.81B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.08%	3.6B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.71%	3.09B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.32%	2.62B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.35%	2.27B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+34.19%	1.82B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.49%	1.41B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.07%	1.38B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.37B

Alternative Medicine

Guizhou Xinbang Pharmaceutical Co., Ltd.

Equities

002390

CNE100000NG5

Pharmaceuticals

China Great Wall Asset Management Corporation sold a 1.24% stake in Guizhou Xinbang Pharmaceutical Co., Ltd.

Latest news about Guizhou Xinbang Pharmaceutical Co., Ltd.

Chart Guizhou Xinbang Pharmaceutical Co., Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Alternative Medicine